Meet the speaker #6 | Perturb 2027

Professor at UCSF and a Core Investigator at the Arc Institute, get to know more about Dr. Gilbert, an early pioneer in repurposed CRISPR systems that are used to turn genes on and off (CRISPRa/i and CRISPRoff/on).

Luke Gilbert from UCSF and Arc Institute, speaker for Perturb 2027

Luke Gilbert

Dr. Luke Gilbert is an Associate Professor at the University of California, San Francisco (UCSF), and a Core Investigator at the Arc Institute of Stanford, UC Berkeley and UCSF. He received his B.S. from UCLA, Ph.D. from MIT and completed his postdoctoral training at UCSF. Dr. Gilbert was an early pioneer in applying CRISPR technology to edit the epigenome, and continues to develop new strategies for editing and understanding human genetics and epigenetics at large scale, with a particular focus on cancer. Dr. Gilbert also co-founded Chroma Medicine in 2020 with the goal of seeing single dose epigenetic editors established as a new type of therapeutic for treatment of human diseases. Dr. Gilbert’s research has been recognized by a NIH Director’s New Innovator Award, a Pew-Stewart scholar for Cancer Research Award, and the AAAS Martin and Rose Wachtel Cancer Research Award.

Information about ticket prices and abstract submissions available at:

More news

Meet the speaker #5 | Perturb 2027

Director of the Gladstone-UCSF Institute of Genomic Immunology and Professor in the UCSF Department of Medicine, get to know more about Dr. Marson’s research with genetically modified T cells.

Myllia announces newly formed board with industry leaders

Single-cell commercial leader Simone Günther, US biotech veteran Sandy Zweifach, and Werner Lanthaler (Wlanholding) join to guide Myllia's next phase of growth

Meet the speaker #4 | Perturb 2027

With a career that spans UCSF, MIT and Gladstones Institutes, get to know more about Dr. Christina Theodoris’s career and research with AI models focused on understanding gene network dynamics.